Article

Shifts in antimalarial drug policy since 2006 have rapidly selected <i>P. falciparum</i> resistance alleles in Angola

2020-09-29

Abstract excerpt

<h4>ABSTRACT</h4> <h4>BACKGROUND</h4> Plasmodium falciparum resistance to chloroquine (CQ), the most widely used antimalarial drug, has historically posed a major threat to malaria control in Angola and throughout the world. Although Angola replaced CQ with artemisinin combination therapy (ACT) as a frontline treatment in 2006, malaria cases and deaths have recently been rising. CQ-resistance mutations may still...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 53fc6023-e9c9-5a28-9160-463e2a0f1309
DOI: 10.1101/2020.09.29.310706

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Shifts in antimalarial drug policy since 2006 have rapidly selected <i>P. falciparum</i> resistance alleles in AngolaDOI 10.1101/2020.09.29.310706Read

Historical trends and new surveillance of Plasmodium falciparum drug resistance markers in AngolaSemantic proximity Read

Drug resistance gene polymorphisms of Plasmodium falciparum Kinshasa clinical isolatesSemantic proximity Read

Understanding the Global Spread of Artemisinin Resistance: Insights from over 100K <i>Plasmodium falciparum</i> SamplesSemantic proximity Read

Spatio-temporal distribution of antimalarial drug resistant gene mutations in a Plasmodium falciparum parasite population from Kilifi, Kenya: A 25-year retrospective studySemantic proximity Read

Xeno-monitoring of molecular drivers of artemisinin and partner drug resistance in <i>P. falciparum</i> populations in malaria vectors across CameroonSemantic proximity Read

Effects of drug pressure and human migration on antimalarial resistance in circulating Plasmodium falciparum malaria parasites in EcuadorSemantic proximity Read

Longitudinal surveillance of kelch13 identifies C469Y, P553L, R561H and A675V mutations associated with artemisinin resistance in Western KenyaSemantic proximity Read

Xeno-monitoring of molecular drivers of artemisinin and partner drug resistance in P. falciparum populations in malaria vectors across CameroonSemantic proximity Read

Emergence and Spread of Plasmodium falciparum Kelch 13 Mutations in Selected Counties of Kenya: Implications for Responding to Artemisinin Partial Resistance.Semantic proximity Read

Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001–2018)Semantic proximity Read

Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015Semantic proximity Read

Sentinel surveillance of the WHO-validated Pfkelch13 C580Y artemisinin resistance marker in Plasmodium falciparum isolates from Bangui, Central African RepublicSemantic proximity Read